---
title: "Peptide-Drug Interactions"
description: "Peptide-drug interactions describe how therapeutic peptides bind to their molecular targets. This article covers binding models, affinity metrics, and practical considerations for drug design."
status: "published"
author: "Wikipept Community"
pubDate: 2026-06-07
tags: ["peptide-drug", "binding-affinity", "pharmacology", "drug-design"]
category: "Pharmacology"
difficulty: "intermediate"
relatedArticles: ["receptor-pharmacology", "gpcr-pharmacology"]
---

## Models of Molecular Recognition

### Lock-and-Key Model

Emil Fischer proposed in 1894 that a drug (the key) fits precisely into a rigid receptor (the lock). This model explains specificity but fails to account for the flexibility observed in most biological molecules.

### Induced Fit Model

Daniel Koshland expanded this idea in 1958, proposing that both the drug and receptor undergo conformational changes upon binding. This model better explains how related drugs can bind the same receptor with different efficacies.

**Mnemonic:** Think of induced fit like a handshake -- both hands adjust their shape when they meet, rather than one rigid hand sliding into a rigid glove.

### Conformational Selection

The modern view combines both models. A receptor exists as an ensemble of conformations. The drug selects and stabilizes the conformation that provides the best fit, shifting the equilibrium toward the bound state.

## Binding Affinity Metrics

### Dissociation Constant (Kd)

Kd represents the concentration at which half of the receptor binding sites are occupied. A lower Kd indicates stronger binding.

- Kd in the nanomolar range (10^-9 M) indicates strong binding
- Kd in the micromolar range (10^-6 M) indicates weak binding

### Inhibition Constant (Ki)

Ki measures how effectively a drug competes with an endogenous ligand. It is determined through competition binding assays and is related to Kd by the Cheng-Prusoff equation: Kd equals Ki times (1 plus [S]/Km).

## Factors Influencing Peptide-Drug Binding

1. **Electrostatic interactions:** Charge complementarity between drug and receptor
2. **Hydrogen bonds:** Directional and distance-dependent
3. **Hydrophobic contacts:** Non-polar surfaces buried at the interface
4. **Shape complementarity:** Van der Waals packing efficiency
5. **Entropic contributions:** Restriction of flexibility upon binding costs entropy

## Practical Considerations

Peptide drugs often face challenges including poor oral bioavailability, rapid enzymatic degradation, and limited membrane permeability. Medicinal chemists address these through cyclization, D-amino acid substitution, PEGylation, and stapling strategies to improve stability while maintaining binding affinity.
